Clinical Trials Browser

Phase 2 × Advanced Endometrial Cancer × anlotinib × Clear all

NCT04574284 2025-05-28

A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer

Phase 2 Completed

Advanced Endometrial Cancer